Del. Farxiga Injury Action Dismissed for Failure to State a Claim
April 14, 2020
DOCUMENTS
- Order
WILMINGTON, Del. — A Delaware judge has dismissed a Farxiga action, ruling that the plaintiff failed to overcome the presumption that AstraZeneca’s warnings, which were approved by the Food and Drug Administration, were adequate as a matter of law.
In a March 2 order, Judge Sheldon K. Rennie of the Delaware Superior Court further held that the defective design claim is defeated by comment k Second Restatement of Torts which states that a drug that is "properly prepared, and accompanied by proper directions and warning, is not defective, nor is it unreasonably dangerous."
Viola Kumaritakis was prescribed Farxiga in October …
UPCOMING CONFERENCES
HarrisMartin's Mass Tort Settlements Conference - Sponsored by Milestone
June 27, 2024 - Buffalo, NY
The Richardson Hotel Buffalo
HarrisMartin's MDL Conference: Video Game Addiction and the Latest Mass Tort Updates
May 29, 2024 - Salt Lake City, UT
The Grand America Hotel